Selected research
Market Analysis & Forecast
Global Cell Biology Services Market Analysis and Forecast 2026-2032
Market perspective
The global Cell Biology Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Cell Biology Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cell Biology Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cell Biology Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cell Biology Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Cell Biology Services include Eurofins Scientific, WuXi AppTec, Labcorp Drug Development, IQVIA Laboratories, Crown Bioscience, BioIVT, GenScript, Creative Bioarray and Creative Biogene, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Cell Biology Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cell Biology Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Biology Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Biology Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Biology Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Biology Services revenue, projected growth trends, production technology, application and end-user industry.
Cell Biology Services Segment by Company
Eurofins Scientific
WuXi AppTec
Labcorp Drug Development
IQVIA Laboratories
Crown Bioscience
BioIVT
GenScript
Creative Bioarray
Creative Biogene
Abzena
Syngene International
Evotec
FUJIFILM Cellular Dynamics
ReproCELL
Takara Bio
Thermo Fisher Scientific
Charles River Laboratories
Lonza
Cell Biology Services Segment by Type
Manufacturing
Testing
Cell Biology Services Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Institutes
Hospitals & Clinical Research Centers
Others
Cell Biology Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Biology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Biology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Biology Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Cell Biology Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Cell Biology Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Biology Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Manufacturing
- Testing
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Clinical Research Centers
- Others
Companies covered
- Eurofins Scientific
- WuXi AppTec
- Labcorp Drug Development
- IQVIA Laboratories
- Crown Bioscience
- BioIVT
- GenScript
- Creative Bioarray
- Creative Biogene
- Abzena
- Syngene International
- Evotec
- FUJIFILM Cellular Dynamics
- ReproCELL
- Takara Bio
- Thermo Fisher Scientific
- Charles River Laboratories
- Lonza
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cell Biology Services Market by Type
- 1.2.1 Global Cell Biology Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Manufacturing
- 1.2.3 Testing
- 1.3 Cell Biology Services Market by Application
- 1.3.1 Global Cell Biology Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Biotechnology Companies
- 1.3.4 Academic & Research Institutes
- 1.3.5 Hospitals & Clinical Research Centers
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cell Biology Services Market Dynamics
- 2.1 Cell Biology Services Industry Trends
- 2.2 Cell Biology Services Industry Drivers
- 2.3 Cell Biology Services Industry Opportunities and Challenges
- 2.4 Cell Biology Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Cell Biology Services Market Perspective (2021-2032)
- 3.2 Global Cell Biology Services Growth Trends by Region
- 3.2.1 Global Cell Biology Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cell Biology Services Market Size by Region (2021-2026)
- 3.2.3 Global Cell Biology Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Cell Biology Services Revenue by Players
- 4.1.1 Global Cell Biology Services Revenue by Players (2021-2026)
- 4.1.2 Global Cell Biology Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Cell Biology Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cell Biology Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Cell Biology Services Key Players Headquarters & Area Served
- 4.4 Global Cell Biology Services Players, Product Type & Application
- 4.5 Global Cell Biology Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Cell Biology Services Market CR5 and HHI
- 4.6.3 2025 Cell Biology Services Tier 1, Tier 2, and Tier 3
5 Cell Biology Services Market Size by Type
- 5.1 Global Cell Biology Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Cell Biology Services Revenue by Type (2021-2032)
- 5.3 Global Cell Biology Services Revenue Market Share by Type (2021-2032)
6 Cell Biology Services Market Size by Application
- 6.1 Global Cell Biology Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Cell Biology Services Revenue by Application (2021-2032)
- 6.3 Global Cell Biology Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Eurofins Scientific
- 7.1.1 Eurofins Scientific Company Information
- 7.1.2 Eurofins Scientific Business Overview
- 7.1.3 Eurofins Scientific Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Eurofins Scientific Cell Biology Services Product Portfolio
- 7.1.5 Eurofins Scientific Recent Developments
- 7.2 WuXi AppTec
- 7.2.1 WuXi AppTec Company Information
- 7.2.2 WuXi AppTec Business Overview
- 7.2.3 WuXi AppTec Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.2.4 WuXi AppTec Cell Biology Services Product Portfolio
- 7.2.5 WuXi AppTec Recent Developments
- 7.3 Labcorp Drug Development
- 7.3.1 Labcorp Drug Development Company Information
- 7.3.2 Labcorp Drug Development Business Overview
- 7.3.3 Labcorp Drug Development Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Labcorp Drug Development Cell Biology Services Product Portfolio
- 7.3.5 Labcorp Drug Development Recent Developments
- 7.4 IQVIA Laboratories
- 7.4.1 IQVIA Laboratories Company Information
- 7.4.2 IQVIA Laboratories Business Overview
- 7.4.3 IQVIA Laboratories Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.4.4 IQVIA Laboratories Cell Biology Services Product Portfolio
- 7.4.5 IQVIA Laboratories Recent Developments
- 7.5 Crown Bioscience
- 7.5.1 Crown Bioscience Company Information
- 7.5.2 Crown Bioscience Business Overview
- 7.5.3 Crown Bioscience Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Crown Bioscience Cell Biology Services Product Portfolio
- 7.5.5 Crown Bioscience Recent Developments
- 7.6 BioIVT
- 7.6.1 BioIVT Company Information
- 7.6.2 BioIVT Business Overview
- 7.6.3 BioIVT Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.6.4 BioIVT Cell Biology Services Product Portfolio
- 7.6.5 BioIVT Recent Developments
- 7.7 GenScript
- 7.7.1 GenScript Company Information
- 7.7.2 GenScript Business Overview
- 7.7.3 GenScript Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.7.4 GenScript Cell Biology Services Product Portfolio
- 7.7.5 GenScript Recent Developments
- 7.8 Creative Bioarray
- 7.8.1 Creative Bioarray Company Information
- 7.8.2 Creative Bioarray Business Overview
- 7.8.3 Creative Bioarray Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Creative Bioarray Cell Biology Services Product Portfolio
- 7.8.5 Creative Bioarray Recent Developments
- 7.9 Creative Biogene
- 7.9.1 Creative Biogene Company Information
- 7.9.2 Creative Biogene Business Overview
- 7.9.3 Creative Biogene Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Creative Biogene Cell Biology Services Product Portfolio
- 7.9.5 Creative Biogene Recent Developments
- 7.10 Abzena
- 7.10.1 Abzena Company Information
- 7.10.2 Abzena Business Overview
- 7.10.3 Abzena Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Abzena Cell Biology Services Product Portfolio
- 7.10.5 Abzena Recent Developments
- 7.11 Syngene International
- 7.11.1 Syngene International Company Information
- 7.11.2 Syngene International Business Overview
- 7.11.3 Syngene International Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Syngene International Cell Biology Services Product Portfolio
- 7.11.5 Syngene International Recent Developments
- 7.12 Evotec
- 7.12.1 Evotec Company Information
- 7.12.2 Evotec Business Overview
- 7.12.3 Evotec Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Evotec Cell Biology Services Product Portfolio
- 7.12.5 Evotec Recent Developments
- 7.13 FUJIFILM Cellular Dynamics
- 7.13.1 FUJIFILM Cellular Dynamics Company Information
- 7.13.2 FUJIFILM Cellular Dynamics Business Overview
- 7.13.3 FUJIFILM Cellular Dynamics Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.13.4 FUJIFILM Cellular Dynamics Cell Biology Services Product Portfolio
- 7.13.5 FUJIFILM Cellular Dynamics Recent Developments
- 7.14 ReproCELL
- 7.14.1 ReproCELL Company Information
- 7.14.2 ReproCELL Business Overview
- 7.14.3 ReproCELL Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.14.4 ReproCELL Cell Biology Services Product Portfolio
- 7.14.5 ReproCELL Recent Developments
- 7.15 Takara Bio
- 7.15.1 Takara Bio Company Information
- 7.15.2 Takara Bio Business Overview
- 7.15.3 Takara Bio Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.15.4 Takara Bio Cell Biology Services Product Portfolio
- 7.15.5 Takara Bio Recent Developments
- 7.16 Thermo Fisher Scientific
- 7.16.1 Thermo Fisher Scientific Company Information
- 7.16.2 Thermo Fisher Scientific Business Overview
- 7.16.3 Thermo Fisher Scientific Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.16.4 Thermo Fisher Scientific Cell Biology Services Product Portfolio
- 7.16.5 Thermo Fisher Scientific Recent Developments
- 7.17 Charles River Laboratories
- 7.17.1 Charles River Laboratories Company Information
- 7.17.2 Charles River Laboratories Business Overview
- 7.17.3 Charles River Laboratories Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.17.4 Charles River Laboratories Cell Biology Services Product Portfolio
- 7.17.5 Charles River Laboratories Recent Developments
- 7.18 Lonza
- 7.18.1 Lonza Company Information
- 7.18.2 Lonza Business Overview
- 7.18.3 Lonza Cell Biology Services Revenue and Gross Margin (2021-2026)
- 7.18.4 Lonza Cell Biology Services Product Portfolio
- 7.18.5 Lonza Recent Developments
8 North America
- 8.1 North America Cell Biology Services Revenue (2021-2032)
- 8.2 North America Cell Biology Services Revenue by Type (2021-2032)
- 8.2.1 North America Cell Biology Services Revenue by Type (2021-2026)
- 8.2.2 North America Cell Biology Services Revenue by Type (2027-2032)
- 8.3 North America Cell Biology Services Revenue Share by Type (2021-2032)
- 8.4 North America Cell Biology Services Revenue by Application (2021-2032)
- 8.4.1 North America Cell Biology Services Revenue by Application (2021-2026)
- 8.4.2 North America Cell Biology Services Revenue by Application (2027-2032)
- 8.5 North America Cell Biology Services Revenue Share by Application (2021-2032)
- 8.6 North America Cell Biology Services Revenue by Country
- 8.6.1 North America Cell Biology Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Cell Biology Services Revenue by Country (2021-2026)
- 8.6.3 North America Cell Biology Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Cell Biology Services Revenue (2021-2032)
- 9.2 Europe Cell Biology Services Revenue by Type (2021-2032)
- 9.2.1 Europe Cell Biology Services Revenue by Type (2021-2026)
- 9.2.2 Europe Cell Biology Services Revenue by Type (2027-2032)
- 9.3 Europe Cell Biology Services Revenue Share by Type (2021-2032)
- 9.4 Europe Cell Biology Services Revenue by Application (2021-2032)
- 9.4.1 Europe Cell Biology Services Revenue by Application (2021-2026)
- 9.4.2 Europe Cell Biology Services Revenue by Application (2027-2032)
- 9.5 Europe Cell Biology Services Revenue Share by Application (2021-2032)
- 9.6 Europe Cell Biology Services Revenue by Country
- 9.6.1 Europe Cell Biology Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Cell Biology Services Revenue by Country (2021-2026)
- 9.6.3 Europe Cell Biology Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Cell Biology Services Revenue (2021-2032)
- 10.2 China Cell Biology Services Revenue by Type (2021-2032)
- 10.2.1 China Cell Biology Services Revenue by Type (2021-2026)
- 10.2.2 China Cell Biology Services Revenue by Type (2027-2032)
- 10.3 China Cell Biology Services Revenue Share by Type (2021-2032)
- 10.4 China Cell Biology Services Revenue by Application (2021-2032)
- 10.4.1 China Cell Biology Services Revenue by Application (2021-2026)
- 10.4.2 China Cell Biology Services Revenue by Application (2027-2032)
- 10.5 China Cell Biology Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cell Biology Services Revenue (2021-2032)
- 11.2 Asia Cell Biology Services Revenue by Type (2021-2032)
- 11.2.1 Asia Cell Biology Services Revenue by Type (2021-2026)
- 11.2.2 Asia Cell Biology Services Revenue by Type (2027-2032)
- 11.3 Asia Cell Biology Services Revenue Share by Type (2021-2032)
- 11.4 Asia Cell Biology Services Revenue by Application (2021-2032)
- 11.4.1 Asia Cell Biology Services Revenue by Application (2021-2026)
- 11.4.2 Asia Cell Biology Services Revenue by Application (2027-2032)
- 11.5 Asia Cell Biology Services Revenue Share by Application (2021-2032)
- 11.6 Asia Cell Biology Services Revenue by Country
- 11.6.1 Asia Cell Biology Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Cell Biology Services Revenue by Country (2021-2026)
- 11.6.3 Asia Cell Biology Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cell Biology Services Revenue (2021-2032)
- 12.2 SAMEA Cell Biology Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Cell Biology Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Cell Biology Services Revenue by Type (2027-2032)
- 12.3 SAMEA Cell Biology Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Cell Biology Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Cell Biology Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Cell Biology Services Revenue by Application (2027-2032)
- 12.5 SAMEA Cell Biology Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Cell Biology Services Revenue by Country
- 12.6.1 SAMEA Cell Biology Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Cell Biology Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Cell Biology Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst